Latest Multiple drug resistance Stories
EMERYVILLE, Calif., Sept. 10 /PRNewswire-FirstCall/ -- NovaBay(R) Pharmaceuticals, Inc.
NEW HAVEN, Conn., Sept. 4 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc., a development-stage company focused on the discovery, development and commercialization of novel antibiotics for the treatment of acute care antibiotic-resistant infections, announced today that Thomas R.
EMERYVILLE, Calif., Sept. 3 /PRNewswire-FirstCall/ -- NovaBay(R) Pharmaceuticals, Inc.
EMERYVILLE, Calif., July 27 /PRNewswire-FirstCall/ -- NovaBay(R) Pharmaceuticals, Inc.
The evolution of multiple antibiotic resistances is a global and difficult problem to eradicate. Isabel Gordo, a group leader at the Instituto Gulbenkian de CiÃªncia (IGC)- Portugal, reports in the paper published in the latest issue of PLoS Genetics
MORGANTOWN, W.Va., July 10 /PRNewswire-USNewswire/ -- Combat-related injuries have long plagued the military in part because of multidrug-resistant bacteria.
NEW HAVEN, Conn., June 30 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc., a development stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic resistant infections, announced today that Russell Greig, Ph.D., of SR One venture capital, has been appointed to the Company's Board of Directors.
SOMERSET, N.J., June 19 /PRNewswire-FirstCall/ -- Dear Shareholder, I am grateful to have this opportunity to share with you important developments taking place at this critical juncture in our company history.
Some disease-causing bacteria are becoming resistant to antibiotics because they have peculiar sex lives, say researchers publishing new results today in the journal Science.
SAN MARINO, Calif., May 21 /PRNewswire-FirstCall/ -- Biotechnology firm Viral Genetics, Inc. (Pink Sheets: VRAL), a company that discovers and develops drug compounds to treat cancer, Lyme Disease and HIV, has been issued a patent for novel cancer therapies.
- a meat pie that is usually eaten at Christmas in Quebec